{reportSlug=global-antirheumatics-pharmaceutical-market, reportId=124749, mktKeyword=Antirheumatics Pharmaceutical, cagr=0.00, publishDate=Dec 2021, priceOption2=7500, reportTitle=Antirheumatics Pharmaceutical Comprehensive Study by Type (Non-Steroidal Anti-Inflammatory Drugs, Steroidal Anti-Inflammatory Drugs, Slow Acting Drug, Immunological Preparation), Application (Pharmaceutical Industry, Hospital and Clinic, Other), Components (Methotrexate, Leflunomide, Hydroxychloroquine, Sulfasalazine), Administration Type (Orally, Subcutaneously (SC), Intravenously (IV)), Distribution Channel (Medical Stores, Pharmaceuticals, Online, Others), Disorder Type (Rheumatoid Arthritis, Systemic Sclerosis, Vasculitis, Spondyloarthritis, Inflammatory Myositis, Inflammatory Bowel Disease, Systemic Lupus Erythematosus, Others), Side Effects (Rash, Diarrhea, Nausea, Abdominal Pain, Others) Players and Region - Global Market Outlook to 2026, baseYr=2021, totalTableFig=212, priceOption1=3750, forecastYr=2027, noOfPages=240, reportKey=124264, breadcrum=Global Antirheumatics Pharmaceutical}
We do not share your information with anyone. However, we may send you
emails based on your report interest from time to time. You may contact
us at any time to opt-out.
Select User Access Type
Key Highlights of Report
Dec 2021
240 Pages
95 Tables
Base Year: 2021Coverage: 15+ Companies; 18
Countries